100%(8)8 out of 8 people found this document helpful
This preview shows page 1 - 4 out of 10 pages.
The preview shows page 2 - 4 out of 10 pages.
1Running Head: AIZHEIMER’S DISEASEAssessing and Treating Clients with Dementia
2ALZHEIMER’S DISEASEAlzheimer’s diseaseAlzheimer’s disease (AD) is an irreversible and slowly progressive neurological diseaseaffecting nearly all functions of the brain, including memory, judgment, personality, rationality,autonomy, and late in the condition, bodily functions (Sade,2018). Alzheimer’s disease is arapidly growing disease with no effective treatment, cure and the cause is unknown. Accordingto Haines, 2018 environmental risk factors include physical trauma (typically head injury), lowereducational attainment, and lifestyle choices including the often-related risk factors of a high-fatdiet, obesity, type II diabetes, and cardiovascular disease. Cognitive enhancing medications andmanagement strategies are used to improve symptoms of Alzheimer’s disease temporarily.The client is Mr. Akkad a 76-year-old Iranian male that came to the office with his oldest son forstrange behavior. His family physician ruled out any organic basis, all laboratory and diagnosticimaging tests were normal. His son stated that the client has been demonstrating some strangethoughts and behaviors that have gotten worse over the past two years. The client began to loseinterest in religious activities with the family and becomes more critical of everyone, and thingshe considered serious becomes a source of amusement and ridicule. His son reports that theclient has been forgetting things and finds it hard finding the right words in conversations andwill shift to an entirely different line of conservation.The client is pleasant, cooperative and enjoys speaking with the practitioner, with someconfabulation during various aspects of the memory testing. Mini-Mental State Exam performed,client, scores 18 out of 30 with primary deficits in orientation, registration, attention andcalculation and recall. The score suggests moderate dementia.The client is a 76-year-old Iranian male, seen today, cooperative, eye contact poor. Hisspeech is clear, coherent, but tangential at times. He makes no unusual motor movements and
3ALZHEIMER’S DISEASEdemonstrates no tic with a self-reported mood of euthymic. Affect is restricted, denies any visualor auditory hallucinations, no delusional or paranoid thought process. The client is alert andoriented to person, partially oriented to place, disoriented to time and event. Insight andjudgment and impulse control are impaired. The client denies any suicidal or homicidal ideation.Diagnosis:Major neurocognitive disorder due to Alzheimer’s disease (presumptive).The purpose of this assignment is to assess and choose medications for a senior man withAlzheimer’s disease to analyze pharmacokinetic and pharmacodynamic factors and also analyzeethical and legal implications for therapy.